Governance Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:48 2026-07-17 EDT			5-day change	1st Jan Change
125.00 ^CHF	+1.41%		+0.58%	+14.05%

07-17	Swiss Market Index Ends Week Upbeat; Georg Fischer Climbs	MT
07-17	AI's Blank Check Is Bouncing

Executive Committee: Novartis AG

Manager

Positions heldSince

Vasant Narasimhan

50 year

Chief Executive Officer

2018-01-31

Charlotte Pamer-Wieser

52 year

Corporate Secretary

2011-08-31

Mukul Mehta

Director of Finance/CFO

2026-03-15

Teresa Jose

58 year

Comptroller/Controller/Auditor

2025-06-30

Maria Victoria Cuevas-Pautonnier

Investor Relations Contact

2021-12-31

Shreeram Aradhye

64 year

Chief Tech/Sci/R&D Officer

2022-05-15

Robert Kowalski

58 year

Human Resources Officer

2021-08-31

Karen Hale

58 year

Compliance Officer	2025-04-13
General Counsel	2021-05-14

Steffen Lang

59 year

Chief Operating Officer

2022-04-03

Composition of the Board of Directors: Novartis AG

Director

CommitteesSince

Giovanni Caforio

61 year

Governance Committee
Nominating Committee
Compensation Committee Chair
HR Committee Chair

Bridgette Heller

65 year

Compensation Committee Chair	2019-09-12
Audit Committee	2020-02-27
Compensation Committee	2020-02-27
Governance Committee	2021-02-01
Nominating Committee	2021-02-01
Finance Committee

Frans van Houten

66 year

Audit Committee
Governance Committee	2025-03-06
Nominating Committee	2025-03-06
Governance Committee Chair
Nominating Committee Chair

Patrice Bula

70 year

Compensation Committee	2019-02-27
Governance Committee Chair	2019-02-27
Nominating Committee Chair	2019-02-27

Simon Moroney

67 year

Compensation Committee Chair	2020-02-27
Compensation Committee	2021-03-31
Nominating Committee	2021-03-31

Ana de Pro Gonzalo

59 year

Audit Committee	2022-03-03
Compensation Committee	2021-12-03
Audit Committee Chair	2020-05-31

Nancy Andrews

67 year

Governance Committee Chair	2025-05-19
Nominating Committee Chair	2025-05-19
Compensation Committee	2021-01-31

John Young

62 year

Compensation Committee Chair
Governance Committee
Compensation Committee	2025-03-06

Liz Doherty Doherty

69 year

Audit Committee Chair

2019-05-09

Ton Büchner

61 year

Audit Committee

2018-03-01

Elizabeth McNally

65 year

Director/Board Member	2025-03-06
Independent Dir/Board Member	2025-03-06

Charles Swanton

54 year

Director/Board Member

2026-03-05

Latest Appointments: Novartis AG

05-04	Kyverna Therapeutics, Inc. Appoints Nadia Dac as Chief Commercial Officer, Effective May 4, 2026	CI
04-29	Olema Pharmaceuticals, Inc. Appoints Prakash Raman, Ph.D., to Board of Directors	CI
04-22	Novabridge Biosciences Appoints Mark Hagler as President and Chief Commercial Officer	CI
04-20	Neurogene Inc. Announces Executive and Board Appointments	CI
04-20	Neurogenesis, Inc. Announces Executive and Board Changes	CI
04-16	Aktis Oncology, Inc. Announces Board and Board Committee Changes	CI
04-15	Tango Therapeutics, Inc. Announces Leadership Appointments	CI

More news

Former Officers and Directors: Novartis AG

Insider

Positions held

SinceUntil

Srikant T. Madhav Datar

Director/Board Member	2002-12-31	2020-12-31
Independent Dir/Board Member	2002-12-31	2020-12-31

Pierre Landolt

Director/Board Member	2010-01-07	2018-03-01
Independent Dir/Board Member	2010-01-07	2018-03-01
Corporate Officer/Principal	1995-12-31	2010-01-07

Joseph Jimenez

Director/Board Member	2009-11-01	2010-01-07
Chief Executive Officer	2010-01-31	2017-12-31
Corporate Officer/Principal	2010-01-07	2010-01-25

Jürgen Brokatzky-Geiger

Human Resources Officer	2004-12-31	2014-03-05
Corporate Officer/Principal	2014-03-05	2017-09-30

Wendelin Wiedeking

Director/Board Member	2002-12-31	2014-02-24
Independent Dir/Board Member	2002-12-31	2014-02-24
Corporate Officer/Principal	2002-12-31	2010-01-07

Rolf M. Zinkernagel

Director/Board Member	2010-01-07	2014-02-24
Independent Dir/Board Member	1998-12-31	2014-02-24
Corporate Officer/Principal	1998-12-31	2010-01-07

Alexandre F. Jetzer-Chung

Director/Board Member	2010-01-07	2011-02-21
Corporate Officer/Principal	1995-12-31	2010-01-07

Raymund Breu

Director of Finance/CFO

1996-11-30

2008-12-31

Hans Jörg Reinhardt

Chief Operating Officer	2007-12-31	2009-12-31
Corporate Officer/Principal	2005-12-31	2007-12-31
Chairman	2012-12-31	2025-03-06
Independent Dir/Board Member	2012-12-31	2025-03-06

William Brody

Director/Board Member	2009-02-23	-
Independent Dir/Board Member	2011-08-24	-

Urs Bärlocher

General Counsel

1998-12-31

2007-08-30

Thomas Ebeling

Corporate Officer/Principal

1999-12-31

2006-12-31

Karen Hübscher

Public Communications Contact

1999-12-31

2005-12-31

Andreas von Planta

Director/Board Member	2005-12-31	-
Independent Dir/Board Member	2005-12-31	-

Pierre F. Dodion

Sales & Marketing

2001-12-31

2005-12-31

François Martelet

Corporate Officer/Principal

2003-06-30

2005-06-30

Ian Garland

Corporate Officer/Principal

2005-05-31

Joachim P. H. Schupp

Corporate Officer/Principal

1984-12-31

2004-09-30

Ronen Tamir

Investor Relations Contact	2011-10-27	-
Public Communications Contact	2011-10-27	-
Corporate Officer/Principal	2003-12-31	2011-10-27

Marshall E. Reese

Corporate Officer/Principal

1998-12-31

2003-12-31

Mihael Polymeropoulos

Corporate Officer/Principal

1997-12-31

2002-12-31

Gilbert Wenzel

Corporate Officer/Principal

2000-10-31

2002-12-31

Paul Herrling

Chief Tech/Sci/R&D Officer

2002-10-31

Bruce F. Fleming

Corporate Officer/Principal

2001-05-31

2002-05-31

Silke Zentner

Public Communications Contact

2002-04-04

Fredrik Ollila

Corporate Officer/Principal

2001-12-31

Paolo Baroldi

Corporate Officer/Principal

1997-12-31

2001-12-31

James New

Corporate Officer/Principal

1998-12-31

Helmut Sihler

Director/Board Member

1995-12-31

Birgit Breuel

Corporate Officer/Principal

1995-12-31

Norman Hardman

Chief Tech/Sci/R&D Officer

1995-12-31

Peter Burckhardt

Director/Board Member	2009-12-30	-
Corporate Officer/Principal	1995-12-31	2009-12-30

John McKenna

Corporate Officer/Principal

1989-12-31

Ann Bailey

Public Communications Contact

1981-12-31

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	2010-04-20	-
President	2009-07-16	2010-04-20

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	21
Female	9

Of which Executive Committee

Male	6
Female	3

Of which Directors

Male	9
Female	3

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).

Employees

75,267

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company